Products
Online Inquiry
Oroxin A
Cat. No.:
0225LY-0852
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Oroxin A is a bioactive compound noted for its pharmacological properties as an expectorant and antitussive.
Synonym:
Baicalein 7-O-glucoside; 57396-78-8; 5,6-dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; OroxinA; Oroxin A; Baicalein-7-O-glucoside; Baikalin; Baicalein 7-O-glucopyranoside; Baicalein 7-O-beta-D-glucoside; 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranosyloxy)-5,6-dihydroxy-2-phenyl-; 5,6-Dihydroxy-2-phenyl-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
CAS No.:
57396-78-8
Compound CID:
5320313
Formula:
C21H20O10
Formula Weight:
432.38
Specification
Relative Density:
1.642±0.06 g/cm3 at 20°C, 760 Torr.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Oroxin A can be used in diabetes research to study the alpha-glucosidase inhibitory activity of natural flavonoids.
Library Information
Target:
PPAR
Receptor:
PPAR
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-11
Plate Location:
h11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
235 mg/mL; 543.5 mM
Solubility:
Soluble in methanol and ethanol.
